+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

AMA's approval of FEC guidelines called restraint of trade by NAFEC



AMA's approval of FEC guidelines called restraint of trade by NAFEC



Emergency Department News 5(9): 1, 12




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 045133755

Download citation: RISBibTeXText

PMID: 10262215


Related references

Infectious disease. Approval of novel TB drug celebrated--with restraint. Science 339(6116): 130, 2013

Restraint of trade. Modern veterinary practice 69(3): 188-189, 1988

Intimidation and restraint of trade. Delaware Medical Journal 62(10): 1311, 1990

Agriculture in the law of restraint on trade. Inf. Steuer Win, Dusseldorf, 17: 23/24, 370-5, 1968

Medical Restraint of Trade Act. Journal of the Medical Association of Georgia 56(6): 271, 1967

Dr. Marcus and the restraint of trade. Journal of the Tennessee Medical Association 79(8): 510-511, 1986

Managed care and restraint of trade. Journal of the Florida Medical Association 80(2): 119-120, 1993

Trade restraint suit filed against AMA. Medical World News 24(15): 74-74, 1983

Withdrawing the approval of the United States from the agreement establishing the World Trade Organization. 2005

Information guidelines for the approval of intensive hog operations. 1999

What is restraint of trade? A review of the nation's antitrust laws. Journal of the American Dental Association 126(11): 1547-1549, 1995

Hospital privileges, restraint of trade, and professional liability. Neurosurgery 10(2): 285-287, 1982

Anti-doping suspensions and restraint of trade in sport. Sports Law Ejournal: 1-8, 2008

Guidelines on restraint. Nursing Standard 1987) 2(17): 4-4, 1988

U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval. Clinical Cancer Research 11(1): 12-19, 2005